Boston Scientific buy The Goldman Sachs Group, Inc.
Start price
27.03.26
/
50%
€60.40
Target price
27.03.27
€80.59
Performance (%)
-32.92%
Price
28.07.26
€40.52
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Boston Scientific is performing very badly with a performance of -32.92%. This prediction currently runs until 27.03.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Boston Scientific | 6.956% | 6.956% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Boston Scientific diskutieren
Boston Scientific (BSX) had its price target lowered by The Goldman Sachs Group, Inc. from $98.00 to $93.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat